Roivant Sciences Ltd.

NASDAQ: ROIVW · Real-Time Price · USD
2.75
0.12 (4.56%)
At close: Jan 16, 2025, 10:00 PM

Roivant Sciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Net Income
-356.73M 4.23B -1.12B -924.12M
Depreciation & Amortization
14.07M 22.04M 18.86M 5.93M
Stock-Based Compensation
289.03M 199.63M 217.78M 564.96M
Other Working Capital
-58.88M -3.65M 1.99M 316K
Other Non-Cash Items
-708.77M -5.24B 29.09M -340.22M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-77.05M 19.04M 6.34M 15.72M
Operating Cash Flow
-839.45M -765.27M -843.39M -677.73M
Capital Expenditures
-4.6M -1.38M -12.69M -17.44M
Cash Acquisitions
229.36M -36.98M 107.86M -39K
Purchase of Investments
-4.06B n/a n/a n/a
Sales Maturities Of Investments
1.96B n/a n/a 320.17M
Other Investing Acitivies
110.47M 5.24B -139.43M 600K
Investing Cash Flow
-1.77B 5.2B -44.27M 303.3M
Debt Repayment
-52.75M -30.7M 129.75M 14.81M
Common Stock Repurchased
-1.29B n/a n/a n/a
Dividend Paid
n/a -6M n/a n/a
Other Financial Acitivies
13.41M 17.51M -10M 291.98M
Financial Cash Flow
-1.22B 419.36M 499.46M 306.79M
Net Cash Flow
-3.82B 4.86B -381.92M -67.64M
Free Cash Flow
-844.05M -766.65M -856.08M -695.16M